Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€165.00

€165.00

0.610%
1.0
0.610%
€166.84

€166.84

 
11:31 / Tradegate WKN: A2JH2F / Symbol: KRYS / Name: Krystal Biotech / Stock / Biotechnology & Medical Research / Small Cap /
Latest predictions
14.03.24
0.61%
buy
€179.60
27.02.24
8.55%
buy
€161.18
27.02.24
8.55%
buy
27.02.24
11.49%
buy
€166.84
13.12.23
57.14%
buy
€146.38
20.11.23
71.88%
buy
Best running prediction
-
17.04.23
102.45%
buy
Your prediction

Krystal Biotech Stock

The Krystal Biotech stock is trending slightly upwards today, with an increase of €1.00 (0.610%) compared to yesterday's price.
With 14 Buy predictions and not the single Sell prediction the community is currently very high on Krystal Biotech.
At the moment Krystal Biotech has reached the predicted target price of 166 €, with a current price of 165.0 €.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Krystal Biotech stock. Negative votes have not been in the majority for any criteria for this stock

Pros and Cons of Krystal Biotech in the next few years

Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
S********** s********
Cons
?
M***** P*******
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Krystal Biotech vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Krystal Biotech 0.610% 6.494% 4.459% 121.622% 41.379% - -
Salarius Pharmaceuticals Inc. 1.470% -21.538% -20.000% -76.920% -26.486% -98.684% -99.992%
Ardelyx Inc. 0.000% -3.641% -22.870% 71.742% 19.031% 28.024% -
Evolus Inc 0.770% 1.563% -2.985% 66.667% 39.037% 31.287% -

Comments

Prediction Buy
Perf. (%) 8.55%
Target price 179.595
Change
Ends at 27.02.25

Krystal Biotech, Inc. (NASDAQ: KRYS) had its price target raised by analysts at Citigroup Inc. from $160.00 to $195.00. They now have a "buy" rating on the stock.
Ratings data for KRYS provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 8.55%
Target price 161.175
Change
Ends at 27.02.25

Krystal Biotech, Inc. (NASDAQ: KRYS) had its price target raised by analysts at Guggenheim from $130.00 to $175.00. They now have a "buy" rating on the stock.
Ratings data for KRYS provided by MarketBeat
Show more

Krystal Biotech, Inc. (NASDAQ: KRYS) had its "outperform" rating re-affirmed by analysts at William Blair.
Ratings data for KRYS provided by MarketBeat
Show more